Cancer Immunology – Products
Product News
Immunovaccine's DepoVax™ Technology Underpins New Experimental Therapy for Cancers
IMV vaccine adjuvant technology of choice for Dana-Farber's HPV-related cancer clinical trial.
Product News
Compugen to Significantly Expand Immuno-Oncology Activities During 2014
R&D expenditures for 2014 anticipated to increase by more than 60%.
Product News
Cell Therapy Company Uses TAP’s Fill-It Automated Cryovial Processing System
To rapidly produce consistent cancer immunotherapy batches and cell banks.
Product News
Life Technologies' OpTmizer™ T-Cell Growth Medium Receives FDA Clearance
Offers cost- and time-saving advantages and is now cleared as a Class II medical device.
Product News
Efficient Transfection of 2 to 6 ml of Cell Suspension
New AgilePulse® MAX system offers the most advanced solution for large volume transfections by utilizing patented Pulse Agile™ technology.
Product News
New Large Volume Transfection System
Ideal for gene or drug delivery, cancer immunotherapy and protein therapeutics applications.
Product News
GeneNews' Sentinel Principle® Used to Discover New Blood Based Biomarkers for NPC
Blood-based biomarkers distinguish NPC patients from controls and from patients with other cancers.
Product News
CureVac Presents Results of a Phase I/IIa Trial in NSCLC with CV9201 at SITC Meeting
High immune response rate of 84% in heavily pre-treated NSCLC patients.
Product News
Adaptimmune Announces Opening of Pilot Clinical Trial in Synovial Sarcoma
Personalized therapy is targeted to patients who have failed initial treatment.
Product News
FDA Approves Immunovaccine's Application for a Phase I/II Clinical Trial for an Ovarian Cancer Vaccine
DPX-Survivac will be tested in patients with ovarian cancer.
Advertisement
